Royal DSM, Solvay eye growth through expansion in emerging markets

09/24/2010 | Reuters

As its Belgian rival Solvay eliminates 800 jobs to streamline its operations, Dutch chemical firm Royal DSM revealed plans to expand in Asia as growth in the European market stagnates. DSM has engaged in deals over the past decade to slowly exit commodity chemicals and focus on niche markets such as nutrition, life sciences and performance materials. Solvay, meanwhile, is trying to hasten its decision-making process for faster project approval, especially for those intended for emerging markets.

View Full Article in:

Reuters

Published in Brief: